Effect of Ketamine in Depressive Symptoms of Elderly Patients With Visual Impairment.
Status:
Completed
Trial end date:
2018-07-30
Target enrollment:
Participant gender:
Summary
the prevalence of depression in elderly is from 4 to 30% and is associated with a lower
quality of life mayor medical comorbidity, and increased mortality. Although there are
various treatments for depression in the elderly, the study of interventions in resistant
depression is limited and there are few reports of the efficacy and safety profile of
alternative interventions such as ketamine in the elderly. The final objective of the present
study is to report the effects of a single infusion of ketamine on the depressive symptoms in
patients undergoing ophthalmologic surgery
Phase:
N/A
Details
Lead Sponsor:
Instituto Mexicano del Seguro Social
Collaborator:
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado